Legal & General Group PLC Igm Biosciences, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 1,746 shares of IGMS stock, worth $18,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,746

Previous 1,746 -0.0%

Holding current value

$18,210

Previous $28,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$6.28 - $17.68 $2,417 - $6,806	385 Added 28.29%	1,746 $28,000
Q2 2024 Aug 14, 2024	BUY	$6.51 - $11.47 $2,200 - $3,876	338 Added 33.04%	1,361 $9,000
Q1 2024 May 14, 2024	SELL	$8.68 - $17.36 $4,904 - $9,808	-565 Reduced 35.58%	1,023 $9,000
Q4 2023 Feb 15, 2024	SELL	$3.94 - $8.79 $49,781 - $111,061	-12,635 Reduced 88.83%	1,588 $13,000
Q3 2023 Nov 14, 2023	BUY	$6.66 - $10.64 $18,195 - $29,068	2,732 Added 23.78%	14,223 $118,000
Q2 2023 Aug 14, 2023	BUY	$8.86 - $14.0 $64,261 - $101,542	7,253 Added 171.14%	11,491 $106,000
Q1 2023 May 15, 2023	BUY	$13.74 - $25.76 $2,610 - $4,894	190 Added 4.69%	4,238 $58,000
Q4 2022 Feb 14, 2023	BUY	$15.45 - $26.02 $6,164 - $10,381	399 Added 10.93%	4,048 $68,000
Q3 2022 Nov 14, 2022	BUY	$15.42 - $27.01 $6,707 - $11,749	435 Added 13.53%	3,649 $83,000
Q2 2022 Aug 22, 2022	BUY	$13.27 - $25.5 $4,870 - $9,358	367 Added 12.89%	3,214 $58,000
Q3 2021 Nov 15, 2021	BUY	$65.76 - $90.65 $99,363 - $136,972	1,511 Added 113.1%	2,847 $186,000
Q2 2021 Aug 12, 2021	BUY	$57.98 - $96.6 $10,900 - $18,160	188 Added 16.38%	1,336 $112,000
Q1 2021 May 17, 2021	BUY	$71.56 - $121.23 $858 - $1,454	12 Added 1.06%	1,148 $88,000
Q4 2020 Feb 12, 2021	SELL	$47.41 - $115.03 $1,896 - $4,601	-40 Reduced 3.4%	1,136 $100,000
Q3 2020 Nov 13, 2020	SELL	$43.0 - $84.01 $13,158 - $25,707	-306 Reduced 20.65%	1,176 $87,000
Q2 2020 Aug 14, 2020	BUY	$51.3 - $75.21 $34,935 - $51,218	681 Added 85.02%	1,482 $109,000
Q1 2020 May 14, 2020	SELL	$31.51 - $73.75 $5,734 - $13,422	-182 Reduced 18.51%	801 $43,000
Q4 2019 Feb 13, 2020	BUY	$17.25 - $49.51 $16,956 - $48,668	983 New	983 $37,000

Others Institutions Holding IGMS

# of Institutions

Shares Held

20.7M

Call Options Held

68K

Put Options Held

52.2K

View Full List

About IGM Biosciences, Inc.

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $302M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

More about IGMS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Igm Biosciences, Inc. Transaction History